Thirty-seven and 16% of the 242 studies mentioning harm-related results used only generic statements to describe AEs and used inadequate metrics, respectively.
Analysis of all patients who completed the study (N=8,672) found that probiotics reduce the risk of CDAD by 60%. Among the probiotic group the incident of CDAD was 1.5% (70/4,525) compared to 4% (164/4,147) in the placebo.
Wellements announced the launch of Wellements Probiotic Gripe Water, the first gripe water to contain probiotics, to help ease a newborn's stomach discomfort often associated with gas, colic, fussiness, and hiccups.
Probiotic supplementation seems beneficial for patients with rheumatoid arthritis (RA), according to a study published online in the International Journal of Rheumatic Diseases.
Infants who developed intolerance to cow's milk showed significant differences in gut bacteria after being treated with probiotics, a new study conducted by researchers from the University of Chicago has found.
Probiotics did not help prevent or eliminate gastrointestinal colonization with drug-resistant organisms in patients in the intensive care unit (ICU) vs. standard care, researchers presented.
Patients who had suffered severe burns were found to have a huge increase in Enterobacteriaceae and a decrease in beneficial bacteria, according to a study published in PLOS ONE.
An analysis performed by researchers at the Celiac Disease Center at Columbia University Medical Center shows that more than half of popular probiotics contain traces of gluten.
New evidence has emerged exploring the relationship between gut microbiome, autism spectrum disorder (ASD), and probiotic treatment.
More patients are turning to probiotics for the promotion of digestive health, but can they also help patients avoid acute upper respiratory tract infections (URTIs), such as the common cold?
Although there are pharmacological therapies for irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC), interest is growing in modulation of GI flora as an alternative treatment.
Prophylaxis with Lactobacillus reuteri DSM 17938 during the first three months of life correlates with a reduction in functional gastrointestinal disorder symptoms and associated costs.
Probiotic exposure in early life may reduce total immunoglobulin E level (IgE) and protect against atopic sensitization, but does not seem to protect against asthma/wheezing.
Production of the proatherosclerotic metabolite trimethylamine-N-oxide (TMAO) is dependent on intestinal microbiota metabolism, and increased TMAO levels correlate with the risk of major adverse cardiovascular events.
Scimera BioScience announced the launch of Asprega ProPac (saccharomyces boulardii 20 billion CFUs) delayed-release capsules, a probiotic to relive gastrointestinal side effects of antibiotic therapy including antibiotic-associated diarrhea (AAD).
Hebron U.S.A. introduced the Florax DS product line featuring the Ready-to-Drink Probiotic for digestive and immune support, and an all-natural probiotic Diarrhea Relief that provides relief of occasional diarrhea, cramping, gas, and bloating without the use of harsh chemicals.
A genetically-engineered tomato containing apoA-I mimetic peptide, and bile salt hydrolase (BSH)-active Lactobacillus reuteri (L. reuteri) NCIMB 30242 capsules may be promising for favorably affecting cholesterol levels.
VSL#3 JUNIOR, a once-daily, high-potency probiotic medical food for the dietary management of children who suffer from irritable bowel syndrome (IBS) and ulcerative colitis (UC) has been launched by Sigma-Tau Pharmaceuticals.